Description: Teyi Pharmaceutical Group Co., Ltd. engages in the research and development, production, and sale of proprietary Chinese medicines, and chemical preparations, raw materials, and products in China. The company offers cough and phlegm, kidney, anti- infection, cardiovascular, and digestive system drugs. Its chemical raw materials and products include aluminum magnesium carbonate, phenytoin, ferrous sulfate, glacial acetic acid, calcium chloride, sodium chloride, bismuth series, citric acid series, zinc sulfate, etc. The company was formerly known as Guangdong Taicheng Pharmaceutical Co., Ltd. and changed its name to Teyi Pharmaceutical Group Co., Ltd. in November 2016. Teyi Pharmaceutical Group Co., Ltd. is based in Taishan, China.
Home Page: www.tczy.com.cn
No. 9, 11, Changxing Road
Taishan,
529200
China
Phone:
86 75 8395 3500
Officers
| Name | Title |
|---|---|
| Mr. Songqing Xu | Deputy Gen. Mang. & Vice Chairman of The Board |
| Mr. Xiliang Chen | CFO, Board Sec. & Director |
Exchange: SHE
Country: CN
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 39.8545 |
| Price-to-Book MRQ: | 5.161 |
| Price-to-Sales TTM: | 7.7986 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1200 |